YonghyunLee5 Profile Banner
Yonghyun Lee Profile
Yonghyun Lee

@YonghyunLee5

Followers
83
Following
1K
Media
4
Statuses
274

Associate Professor, College of Pharmacy, Ewha Womans University. Nanomedicine, Immunotherapy, Gut microbiome, IBD therapy, Cancer therapy

Joined August 2019
Don't wanna be here? Send us removal request.
@KoreaCRS
CRS Korea Chapter
1 year
0
9
19
@KoreaCRS
CRS Korea Chapter
1 year
Don't miss out! 🗓️ Early bird registration is open until Sep 30th. Get all the details and sign up here: https://t.co/pQb3OHqSEx #KSPST2024 @CRSscience @twan_lammers @YoonYeo4 @CRSNordicLocal @CRS_SPLC @CRS_GermanChapt @CRSMalaysia @AustralianCRS @CRS_YSC @CRSBeNeLuxFr
0
5
10
@KoreaCRS
CRS Korea Chapter
1 year
Kicking off #APDSC2024 (Asia Pacific Delivery System Conference 2024), co-hosted by @AustralianCRS, @CRSMalaysia, and the CRS Chinese Taipei local chapters. Check out more info below! https://t.co/MelxNYE6ky
crsmalaysiainfo.wixsite.com
@CRSMalaysia
CRS Malaysia Local Chapter (MyCRS)
1 year
Live now! Opening ceremony of the Asia Pacific Delivery Science Conference 2024 Honoured to have Prof Dato’ Dr Adeeba, President & Pro Vice Cancellor, Monash University Malaysia to officiate our #APDSC2024 #MyCRS #MyCRS10years @CRS_TW_Local @nz_crs @AustralianCRS
0
1
3
@KoreaCRS
CRS Korea Chapter
1 year
Please don't miss the upcoming JCR Best Paper Award Webinar! @KSPST1971 August 30th (Fri). 12:00 UTC, 08:00 ET, 21:00 KTC. https://t.co/9QzOTuIldV ID: 821 0368 0115 PW: 817741
1
3
8
@NPeppas
Nicholas A. Peppas
1 year
History of ChE, BME, Biomaterials, Drug Delivery, Nanotechnology. Bob Langer, Michael Sefton and @NPeppas as ChE grad students in the MIT labs in May 1972
0
2
55
@CRSScience
Controlled Release Society
1 year
We are delighted and honored to announce that registration for #CRS2024 has SOLD OUT! With 1,650 attendees representing 51 countries, this is sure to be one of our best Annual Meetings yet. Stay tuned for our upcoming announcement about next year's meeting location. (Hint: đź””)
0
6
29
@twan_lammers
Twan Lammers
1 year
“EPR effect vs. ATR concept” 🎯 Do nanomedicines accumulate in tumors passively or actively? Is this different in different tumor types, or for soft vs. hard nanoparticles? How do new targeting mechanisms contribute to clinical impact? Check out https://t.co/PdkdmsQqKR
2
25
110
@acsnano
ACS Nano
2 years
Anti-oxidative Hyaluronic Acid–bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-hepatic-fibrosis Therapy. By @YonghyunLee5 (@EwhaWomansUniv) @KoreaCRS #NASH #liverfibrosis #Bilirubin #Hyaluronicacid Read it here 🔗 https://t.co/iYTkQUgmZm
0
3
4
@YonghyunLee5
Yonghyun Lee
2 years
Great talks at last night's @KoreaCRS webinar session with Prof. Wooram Park (@SKKU_1398) and Prof. So-Yeon Park (@EwhaWomansUniv). Big thanks to Prof. Hyukjin Lee for moderating the session of the webinar co-hosted by @AustralianCRS and CRSchina.
0
2
4
@YonghyunLee5
Yonghyun Lee
2 years
Good lecture for the students!
@twan_lammers
Twan Lammers
2 years
Summary of the lecture in written form: https://t.co/nIHvzF3Aow …
0
0
0
@NatureMedicine
Nature Medicine
2 years
Understanding the dynamics of the gut #Microbiota over the course of #Cancer treatment regimens and their associated adverse events can help identify microbial features that associate with response to immune checkpoint blockade.
Tweet card summary image
nature.com
Nature Medicine - Understanding the dynamics of the gut microbiota over the course of cancer treatment regimens and their associated adverse events can help identify microbial features that...
1
48
144
@YonghyunLee5
Yonghyun Lee
2 years
Good review article discussing nanoparticle delivery mechanisms published in @NatRevDrugDisc
@natrevbioeng
Nature Reviews Bioengineering
2 years
A nanoparticle delivery paradigm in cancer – the EPR effect - has been challenged, shifting the focus to active delivery mechanisms. In their Review, Warren Chan et al explore passive vs active delivery and the impact on nanoparticle design @TheChanLab https://t.co/MnhZcUj0z9
0
0
2
@KoreaCRS
CRS Korea Chapter
2 years
Outstanding paper of Prof. Kwangmeyung Kim on chemodrug-loaded nanomedicines for combination cancer immunotherapy published in @KSPST1971. @EwhaWomansUniv
@KSPST1971
KSPST
2 years
Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy | Kwangmeyung Kim @EwhaWomansUniv | #nanomedicine #chemotherapy #cancerimmunotherapy https://t.co/2JoI2j9rZH
0
1
7
@KoreaCRS
CRS Korea Chapter
2 years
Congrats on the launch of the official Twitter account for the Korean Society of Pharmaceutical Science and Technology and its official journal, the Journal of Pharmaceutical Investigation ( https://t.co/3ytRwq3vvg)! @CRSScience
Tweet card summary image
link.springer.com
Journal of Pharmaceutical Investigation is an international, peer-reviewed journal that covers all aspects of pharmaceutical sciences. It includes studies ...
@KSPST1971
KSPST
2 years
This is the official X (Twitter) account of Korean Society of Pharmaceutical Science and Technology.
1
3
16
@YonghyunLee5
Yonghyun Lee
2 years
Very interesting paper of @ysyoun0915 on a cancer #immunotherapy strategy utilizing cancer cell membrane-coated liposomes published in @KSPST1971.
@KSPST1971
KSPST
2 years
Cancer cell membrane-decorated hybrid liposomes for treating metastatic breast cancer based on enhanced cancer immunotherapy | Yu Seok Youn, Sungkyunkwan University | #cellmembrane #hybridliposome #breastcancer #cancerimmunotherapy https://t.co/tvuDBjPvbe
0
2
6
@YonghyunLee5
Yonghyun Lee
2 years
Delighted to share our group's recent work on a novel anti-fibrosis strategy utilizing hyaluronic acid-bilirubin nanomedicine published in @acsnano (First authored by our group's Ph.D. student @JongyoonShinn). @KoreaCRS @EwhaWomansUniv
Tweet card summary image
pubs.acs.org
Liver fibrosis is a life-threatening and irreversible disease. The fibrosis process is largely driven by hepatic stellate cells (HSCs), which undergo transdifferentiation from an inactivated state to...
1
0
10
@KoreaCRS
CRS Korea Chapter
2 years
We're very excited to announce our @KoreaCRS 2024 Board Members! Looking forward to their exciting and important roles. @AustralianCRS @CRSBeNeLuxFr @brazilCRS @CrsIndian @CRS_Italia @CRS_GermanChapt @CRSNordicLocal @nz_crs @CRS_SPLC @CRS_Turkey @CRS_TW_Local @UKICRS @CRSScience
0
2
13
@YonghyunLee5
Yonghyun Lee
2 years
Please join @CRSScience for free
@twan_lammers
Twan Lammers
2 years
Become a CRS member for FREE ✅ Are you passionate about drug delivery research, but unable to cover the membership fee? Then check out our new Sponsored Membership Program👇 Several sponsors have already signed up. Apply today to profit from their generosity! Pls retweet 🙏
0
0
3